Rating History for Larimar Therapeutics (LRMR) by Leerink
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/14/2026 | Joseph Schwartz | New Coverage | Outperform (N/A) |
13.00 (N/A) |
3.92 (2.35) |
-40.05% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/14/2026 | Joseph Schwartz | New Coverage | Outperform (N/A) |
13.00 (N/A) |
3.92 (2.35) |
-40.05% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||